F. Wingen

发表

Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256.

M. Müller, B. Krempien, F. Wingen, 1988, Oncology.

Changing metastatic patterns of a transplantable rat osteosarcoma

E. Weber, F. Wingen, 2004, Clinical & Experimental Metastasis.

Pharmacokinetics of the osteotropic diphosphonate 3-amino-1-hydroxypropane-1,1-diphosphonic acid in mammals.

F. Wingen, D. Schmähl, 1987, Arzneimittel-Forschung.

Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat — benefit of combining bisphosphonates with cytostatic agents

B. Pool, T. Klenner, F. Wingen, 1988, Investigational New Drugs.

In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. Typhimurium

B. Pool, M. Berger, J. Schlehofer, 1988, Investigational New Drugs.

Antimetastatic effects of razoxane in a rat osteosarcoma model

H. Spring, F. Wingen, D. Schmähl, 2004, Clinical & Experimental Metastasis.

Distribution of 3-amino-1-hydroxypropane-1,1-diphosphonic acid in rats and effects on rat osteosarcoma.

F. Wingen, D. Schmähl, 1985, Arzneimittel-Forschung.

Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?

B. Keppler, T. Klenner, B. Krempien, 2005, Journal of Cancer Research and Clinical Oncology.

Synthesis, antitumor activity, distribution and toxicity of 4-[4-[Bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma

H. Spring, B. Pool, H. Sinn, 2004, Journal of Cancer Research and Clinical Oncology.

Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat

B. Keppler, T. Klenner, F. Wingen, 1990, Clinical & Experimental Metastasis.

Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo.

B. Keppler, T. Klenner, H. Scherf, 1990, Cancer treatment reviews.

Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat

C. Manegold, B. Krempien, F. Wingen, 2004, Journal of Cancer Research and Clinical Oncology.

Intraosseously transplantable osteosarcoma with regularly disseminating pulmonary metastases in rats.

H. Spring, M. Berger, F. Wingen, 1984, Cancer letters.